Cancer

Lin Health Raises $11 Million Series A to Fuel Growth of Virtual Chronic Pain Recovery Platform

Oversubscribed round demonstrates strong investor confidence in Lin Health's neuroscience-based approach to chronic painDENVER, Dec. 9, 2025 /PRNewswire/ -- Lin…

2 weeks ago

Sage Growth Partners Honored for Healthcare Marketing Campaign of the Year at 2025 PR Daily Awards

Annual awards recognize industry's most successful campaigns, initiatives, people, and teamsBALTIMORE, Dec. 9, 2025 /PRNewswire/ -- Sage Growth Partners (Sage), a…

2 weeks ago

Vincere Cancer Center Begins Recruitment for Clinical Studies of Pioneering Breast Cancer Screen for Women at High Risk

US cancer center partners with Syantra Inc. for further testing of Onco-ID Breast, a whole blood mRNA test for hyper-early…

2 weeks ago

Cypherpunk Taps Zcash Founder Zooko as Strategic Advisor

CAMBRIDGE, Mass., Dec. 9, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc. (Nasdaq: CYPH) today announced that industry pioneer Zooko Wilcox, the founder…

2 weeks ago

The Longevity Center Introduces Ozone Shots as New Option for Prostate Health

The newly offered, targeted ozone injections are a minimally invasive therapy with potential benefits for prostate tissue and function GREENVILLE,…

2 weeks ago

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

100% of patients in Cohorts 1-3 remain free of cytokine release syndromeCRIS-7-derived CD3 design underpins a controlled T-cell response, supporting…

2 weeks ago

Akari Therapeutics Highlights Preclinical Data Demonstrating Therapeutic Potential of Lead Candidate, AKTX-101, for Hard-to-Treat K-Ras Mutant Pancreatic Cancer

Data highlights the ability of Akari’s Trop2 ADC, AKTX-101, to kill K-Ras G12V mutated cancer cell lines in preclinical models,…

2 weeks ago

The Jackson Laboratory receives an up to $30 million contract award to revolutionize drug safety testing with AI-powered “virtual hearts”

New CARDIOVERSE project combines AI, stem cells, and genetic variation to predict drug safety before human trialsBAR HARBOR, Maine, Dec.…

2 weeks ago

Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders

Jaguar CEO Lisa Conte presenting December 10 from 3:25pm - 3:35pm Eastern at the Emerging Growth Conference to provide updates…

2 weeks ago

Abbott’s Lingo™ Now on Android™, Expanding Access to Real-Time Glucose Data

Lingo, Abbott's first over-the-counter biowearable, expands to Android devicesContinuous glucose monitoring devices help people maintain healthy glucose levels, which are…

2 weeks ago